Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression

Biochemical Journal

Volumn 441, Issue 2, 2012, Pages 541-552

  Shields, Mario A ^a   Dangi Garimella, Surabhi ^a   Redig, Amanda J ^b   Munshi, Hidayatullah G ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemoresistance; Fibrosis; Membrane type 1 matrix metalloproteinase (MT1 MMP); MicroRNA; Pancreatic cancer; Snail; Transforming growth factor (TGF )

Indexed keywords

COLLAGEN TYPE 1; MATRIX METALLOPROTEINASE 14; MICRORNA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1;

CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; FIBROSIS; HUMAN; MYOFIBROBLAST; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

CARCINOMA, PANCREATIC DUCTAL; COLLAGEN TYPE I; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FIBROSIS; HUMANS; MATRIX METALLOPROTEINASE 14; MICRORNAS; MYOFIBROBLASTS; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

GASTROPODA;

EID: 84555178641     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111240     Document Type: Review

References (180)

1. Malvezzi, M., Arfe, A., Bertuccio, P., Levi, F., La Vecchia, C. and Negri, E. (2011) European cancer mortality predictions for the year 2011. Ann. Oncol. 22, 947-956
2. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90
3. Siegel, R., Ward, E., Brawley, O. and Jemal, A. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212-236
4. Hidalgo, M. (2010) Pancreatic cancer. N. Engl. J. Med. 362, 1605-1617
5. Vincent, A., Herman, J., Schulick, R., Hruban, R. H. and Goggins, M. (2011) Pancreatic cancer. Lancet 378, 607-620
6. Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S. et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J. Gastrointest. Surg. 10, 1199-1210
7. Maitra, A. and Hruban, R. H. (2008) Pancreatic cancer. Annu. Rev. Pathol. 3, 157-188 (Pubitemid 351488279)
8. Chu, G. C., Kimmelman, A. C., Hezel, A. F. and DePinho, R. A. (2007) Stromal biology of pancreatic cancer. J. Cell. Biochem. 101, 887-907 (Pubitemid 47040870)
9. Mahadevan, D. and Von Hoff, D. D. (2007) Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 6, 1186-1197 (Pubitemid 46711982)
10. Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D. et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461
11. Dangi-Garimella, S., Krantz, S. B., Barron, M. R., Shields, M. A., Heiferman, M. J., Grippo, P. J., Bentrem, D. J. and Munshi, H. G. (2011) Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res. 71, 1019-1028
12. Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S. and DePinho, R. A. (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17, 3112-3126 (Pubitemid 38040774)
13. Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A. et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (Pubitemid 38050041)
14. Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S. and Tuveson, D. A. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483 (Pubitemid 40719130)
15. Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K. H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U. et al. (2006) Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl. Acad. Sci. U.S.A. 103, 5947-5952
16. Imamura, T., Iguchi, H., Manabe, T., Ohshio, G., Yoshimura, T., Wang, Z. H., Suwa, H., Ishigami, S. and Imamura, M. (1995) Quantitative analysis of collagen and collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic pancreatitis, and alcoholic chronic pancreatitis. Pancreas 11, 357-364
17. Mollenhauer, J., Roether, I. and Kern, H. F. (1987) Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas 2, 14-24
18. Linder, S., Castanos-Velez, E., von Rosen, A. and Biberfeld, P. (2001) Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 48, 1321-1327 (Pubitemid 33010416)
19. Apte, M. V., Haber, P. S., Applegate, T. L., Norton, I. D., McCaughan, G. W., Korsten, M. A., Pirola, R. C. and Wilson, J. S. (1998) Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43, 128-133 (Pubitemid 28335501)
20. Bachem, M. G., Schneider, E., Gross, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grunert, A. and Adler, G. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115, 421-432
21. Yen, T. W., Aardal, N. P., Bronner, M. P., Thorning, D. R., Savard, C. E., Lee, S. P. and Bell, Jr, R. H. (2002) Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 131, 129-134 (Pubitemid 34169536)
22. Maehara, N., Matsumoto, K., Kuba, K., Mizumoto, K., Tanaka, M. and Nakamura, T. (2001) NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br. J. Cancer 84, 864-873 (Pubitemid 32275664)
23. Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., Ji, B., Evans, D. B. and Logsdon, C. D. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68, 918-926 (Pubitemid 351206771)
24. Sato, N., Maehara, N. and Goggins, M. (2004) Gene expression profiling of tumorstromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 64, 6950-6956 (Pubitemid 39331004)
25. Kadler, K. (1995) Extracellular matrix 1: fibril-forming collagens. Protein Profile 2, 491-619
26. Munshi, H. G. and Stack, M. S. (2002) Analysis of matrix degradation. Methods Cell Biol. 69, 195-205 (Pubitemid 44245293)
27. Kadler, K. E., Baldock, C., Bella, J. and Boot-Handford, R. P. (2007) Collagens at a glance. J. Cell Sci. 120, 1955-1958 (Pubitemid 47009991)
28. Munshi, H. G. and Stack, M. S. (2006) Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 25, 45-56 (Pubitemid 43723981)
29. Sternlicht, M. D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516 (Pubitemid 33096184)
30. Song, F., Wisithphrom, K., Zhou, J. and Windsor, L. J. (2006) Matrix metalloproteinase dependent and independent collagen degradation. Front. Biosci. 11, 3100-3120 (Pubitemid 43800400)
31. Condeelis, J. and Segall, J. E. (2003) Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 3, 921-930 (Pubitemid 37500177)
32. Provenzano, P., Eliceiri, K., Campbell, J., Inman, D., White, J. and Keely, P. (2006) Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38
33. Tavazoie, S. F., Alarcon, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L. and Massague, J. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152
34. Ramaswamy, S., Ross, K. N., Lander, E. S. and Golub, T. R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (Pubitemid 36068681)
35. Erkan, M., Michalski, C. W., Rieder, S., Reiser-Erkan, C., Abiatari, I., Kolb, A., Giese, N. A., Esposito, I., Friess, H. and Kleeff, J. (2008) The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin. Gastroenterol. Hepatol. 6, 1155-1161
36. Ottaviano, A. J., Sun, L., Ananthanarayanan, V. and Munshi, H. G. (2006) Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-β1. Cancer Res. 66, 7032-7040 (Pubitemid 44197679)
37. Shields, M. A., Dangi-Garimella, S., Krantz, S. B., Bentrem, D. J. and Munshi, H. G. (2011) Pancreatic cancer cells respond to type I collagen by inducing Snail expression to promote membrane type 1 matrix metalloproteinase- dependent collagen invasion. J. Biol. Chem. 286, 10495-10504
38. Makareeva, E., Han, S., Vera, J. C., Sackett, D. L., Holmbeck, K., Phillips, C. L., Visse, R., Nagase, H. and Leikin, S. (2010) Carcinomas contain a matrix metalloproteinaseresistant isoform of type I collagen exerting selective support to invasion. Cancer Res. 70, 4366-4374
39. Han, S., Makareeva, E., Kuznetsova, N. V., DeRidder, A. M., Sutter, M. B., Losert, W., Phillips, C. L., Visse, R., Nagase, H. and Leikin, S. (2010) Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases. J. Biol. Chem. 285, 22276-22281
40. Kadler, K. E., Holmes, D. F., Trotter, J. A. and Chapman, J. A. (1996) Collagen fibril formation. Biochem. J. 316, 1-11 (Pubitemid 26158194)
41. Pucci-Minafra, I., Andriolo, M., Basirico, L., Alessandro, R., Luparello, C., Buccellato, C., Garbelli, R. and Minafra, S. (1998) Absence of regular α2(I) collagen chains in colon carcinoma biopsy fragments. Carcinogenesis 19, 575-584 (Pubitemid 28376799)
42. Shapiro, F. D. and Eyre, D. R. (1982) Collagen polymorphism in extracellular matrix of human osteosarcoma. J. Natl. Cancer Inst. 69, 1009-1016 (Pubitemid 13254889)
43. Minafra, S., Luparello, C., Rallo, F. and Pucci-Minafra, I. (1988) Collagen biosynthesis by a breast carcinoma cell strain and biopsy fragments of the primary tumour. Cell Biol. Int. Rep. 12, 895-905
44. DeClerck, Y. A., Bomann, E. T., Spengler, B. A. and Biedler, J. L. (1987) Differential collagen biosynthesis by human neuroblastoma cell variants. Cancer Res. 47, 6505-6510 (Pubitemid 18019645)
45. Rupard, J. H., Dimari, S. J., Damjanov, I. and Haralson, M. A. (1988) Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. Am. J. Pathol. 133, 316-326 (Pubitemid 19017493)
46. Schillaci, R., Luparello, C. and Minafra, S. (1989) Type I and I-trimer collagens as substrates for breast carcinoma cells in culture. Effect on growth rate, morphological appearance and actin organization. Eur. J. Cell Biol. 48, 135-141
47. Luparello, C., Sheterline, P., Pucci-Minafra, I. and Minafra, S. (1991) A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion. J. Cell Sci. 100, 179-185 (Pubitemid 21925048)
48. Apte, M. V. and Wilson, J. S. (2004) Mechanisms of pancreatic fibrosis. Dig. Dis. 22, 273-279 (Pubitemid 40467602)
49. Van Hoorde, L., Van Aken, E. and Mareel, M. (2000) Collagen type I: a substrate and a signal for invasion. Prog. Mol. Subcell. Biol. 25, 105-134
50. Henriet, P., Zhong, Z. D., Brooks, P. C., Weinberg, K. I. and DeClerck, Y. A. (2000) Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc. Natl. Acad. Sci. U.S.A. 97, 10026-10031
51. Schocklmann, H. O., Lang, S., Kralewski, M., Hartner, A., Ludke, A. and Sterzel, R. B. (2000) Distinct structural forms of type I collagen modulate cell cycle regulatory proteins in mesangial cells. Kidney Int. 58, 1108-1120
52. Taki, M., Verschueren, K., Yokoyama, K., Nagayama, M. and Kamata, N. (2006) Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int. J. Oncol. 28, 487-496
53. Li, S., Lao, J., Chen, B. P., Li, Y. S., Zhao, Y., Chu, J., Chen, K. D., Tsou, T. C., Peck, K. and Chien, S. (2003) Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J. 17, 97-99
54. Fassett, J. T., Tobolt, D., Nelsen, C. J., Albrecht, J. H. and Hansen, L. K. (2003) The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes. J. Biol. Chem. 278, 31691-31700 (Pubitemid 37048348)
55. Paszek, M. J. and Weaver, V. M. (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia 9, 325-342 (Pubitemid 41149140)
56. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D. et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254 (Pubitemid 41317594)
57. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W. et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906
58. Dai, Y., Chen, S., Pei, X. Y., Almenara, J. A., Kramer, L. B., Venditti, C. A., Dent, P. and Grant, S. (2008) Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells. Blood 112, 2439-2449
59. Matsumoto, K., Nagahara, T., Okano, J. and Murawaki, Y. (2008) The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases. Oncol. Rep. 20, 863-872
60. Zhao, Y., Shen, S., Guo, J., Chen, H., Greenblatt, D. Y., Kleeff, J., Liao, Q., Chen, G., Friess, H. and Leung, P. S. (2006) Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. J. Surg. Res. 136, 325-335 (Pubitemid 44737848)
61. Hodkinson, P. S., Mackinnon, A. C. and Sethi, T. (2007) Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int. J. Radiat. Biol. 83, 733-741 (Pubitemid 350219111)
62. Iacobuzio-Donahue, C. A., Ryu, B., Hruban, R. H. and Kern, S. E. (2002) Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. Am. J. Pathol. 160, 91-99 (Pubitemid 34052270)
63. Imamura, T., Ohshio, G., Mise, M., Harada, T., Suwa, H., Okada, N., Wang, Z., Yoshitomi, S., Tanaka, T., Sato, H. et al. (1998) Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas. J. Cancer Res. Clin. Oncol. 124, 65-72 (Pubitemid 28161282)
64. Bramhall, S. R., Neoptolemos, J. P., Stamp, G. W. and Lemoine, N. R. (1997) Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J. Pathol. 182, 347-355 (Pubitemid 27285789)
65. Ellenrieder, V., Alber, B., Lacher, U., Hendler, S. F., Menke, A., Boeck, W., Wagner, M., Wilda, M., Friess, H., Buchler, M. et al. (2000) Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer 85, 14-20
66. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I. et al. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92 (Pubitemid 29468632)
67. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y. and Tryggvason, K. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U.S.A. 97, 4052-4057 (Pubitemid 30226085)
68. Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W. and Weiss, S. J. (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33-45 (Pubitemid 36859839)
69. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S. et al. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781 (Pubitemid 39565156)
70. Ha, H. Y., Moon, H. B., Nam, M. S., Lee, J. W., Ryoo, Z. Y., Lee, T. H., Lee, K. K., So, B. J., Sato, H., Seiki, M. et al. (2001) Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res. 61, 984-990 (Pubitemid 32174415)
71. Soulie, P., Carrozzino, F., Pepper, M. S., Strongin, A. Y., Poupon, M. F. and Montesano, R. (2005) Membrane-type-1 matrix metalloproteinase confers tumorigenicity on non-malignant epithelial cells. Oncogene 24, 1689-1697 (Pubitemid 40467524)
72. Dangi-Garimella, S., Redig, A. J., Shields, M. A., Siddiqui, M. A. and Munshi, H. G. (2010) Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J. Biol. Chem. 285, 28363-28372
73. Krantz, S. B., Shields, M. A., Dangi-Garimella, S., Cheon, E., Barron, M. R., Hwang, R. F., Rao, M. S., Grippo, P. J., Bentrem, D. J. and Munshi, H. G. (2011) MT1-MMP cooperates with KrasG12D to promote pancreatic fibrosis through increased TGF-βsignaling. Mol. Cancer Res. 9, 1294-1304
74. Cukierman, E., Pankov, R., Stevens, D. R. and Yamada, K. M. (2001) Taking cell-matrix adhesions to the third dimension. Science 294, 1708-1712 (Pubitemid 33104840)
75. Baciu, P. C., Suleiman, E. A., Deryugina, E. I. and Strongin, A. Y. (2003) Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-αv integrin regulates cross-talk between αvβ3 and α2β1 integrins in breast carcinoma cells. Exp. Cell Res. 291, 167-175 (Pubitemid 37338690)
76. Duxbury, M. S., Ito, H., Benoit, E., Waseem, T., Ashley, S. W. and Whang, E. E. (2005) RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin. Cancer Res. 11, 3433-3438 (Pubitemid 40627897)
77. Gingras, D., Bousquet-Gagnon, N., Langlois, S., Lachambre, M. P., Annabi, B. and Beliveau, R. (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 507, 231-236 (Pubitemid 33001548)
78. D'Alessio, S., Ferrari, G., Cinnante, K., Scheerer, W., Galloway, A. C., Roses, D. F., Rozanov, D. V., Remacle, A. G., Oh, E. S., Shiryaev, S. A. et al. (2008) Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J. Biol. Chem. 283, 87-99
79. Takino, T., Tsuge, H., Ozawa, T. and Sato, H. (2010) MT1-MMP promotes cell growth and ERK activation through c-Src and paxillin in three-dimensional collagen matrix. Biochem. Biophys. Res. Commun. 396, 1042-1047
80. Dangi-Garimella, S., Strouch, M. J., Grippo, P. J., Bentrem, D. J. and Munshi, H. G. (2011) Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 30, 1002-1008
81. Lehti, K., Allen, E., Birkedal-Hansen, H., Holmbeck, K., Miyake, Y., Chun, T. H. and Weiss, S. J. (2005) An MT1-MMP-PDGF receptor-β axis regulates mural cell investment of the microvasculature. Genes Dev. 19, 979-991 (Pubitemid 40548065)
82. Hammond, S. M. and Sharpless, N. E. (2008) HMGA2, microRNAs, and stem cell aging. Cell 135, 1013-1016
83. Pfannkuche, K., Summer, H., Li, O., Hescheler, J. and Droge, P. (2009) The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? Stem Cell Rev. 5, 224-230
84. Liau, S. S. and Whang, E. (2008) HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma. Clin. Cancer Res. 14, 1470-1477
85. Summer, H., Li, O., Bao, Q., Zhan, L., Peter, S., Sathiyanathan, P., Henderson, D., Klonisch, T., Goodman, S. D. and Droge, P. (2009) HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy. Nucleic Acids Res. 37, 4371-4384
86. Palmieri, D., Valentino, T., D'Angelo, D., De Martino, I., Postiglione, I., Pacelli, R., Croce, C. M., Fedele, M. and Fusco, A. (2011) HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene 30, 3024-3035
87. Boman, B. M. and Wicha, M. S. (2008) Cancer stem cells: a step toward the cure. J. Clin. Oncol. 26, 2795-2799
88. Haas, T. L., Stitelman, D., Davis, S. J., Apte, S. S. and Madri, J. A. (1999) Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem. 274, 22679-22685
89. Yun, S., Dardik, A., Haga, M., Yamashita, A., Yamaguchi, S., Koh, Y., Madri, J. A. and Sumpio, B. E. (2002) Transcription factor Sp1 phosphorylation induced by shear stress inhibits membrane type 1-matrix metalloproteinase expression in endothelium. J. Biol. Chem. 277, 34808-34814
90. Barbolina, M. V., Adley, B. P., Ariztia, E. V., Liu, Y. and Stack, M. S. (2007) Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J. Biol. Chem. 282, 4924-4931 (Pubitemid 47100955)
91. Takahashi, M., Tsunoda, T., Seiki, M., Nakamura, Y. and Furukawa, Y. (2002) Identification of membrane-type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21, 5861-5867 (Pubitemid 35007236)
92. Miyoshi, A., Kitajima, Y., Sumi, K., Sato, K., Hagiwara, A., Koga, Y. and Miyazaki, K. (2004) Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br. J. Cancer 90, 1265-1273 (Pubitemid 38496823)
93. Miyoshi, A., Kitajima, Y., Kido, S., Shimonishi, T., Matsuyama, S., Kitahara, K. and Miyazaki, K. (2005) Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br. J. Cancer 92, 252-258 (Pubitemid 40343137)
94. Ota, I., Li, X. Y., Hu, Y. and Weiss, S. J. (2009) Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. U.S.A. 106, 20318-20323
95. Rowe, R. G., Li, X. Y., Hu, Y., Saunders, T. L., Virtanen, I., Garcia de Herreros, A., Becker, K. F., Ingvarsen, S., Engelholm, L. H., Bommer, G. T. et al. (2009) Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J. Cell Biol. 184, 399-408
96. Friess, H., Yamanaka, Y., Buchler, M., Ebert, M., Beger, H. G., Gold, L. I. and Korc, M. (1993) Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105, 1846-1856 (Pubitemid 24002804)
97. Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. and Depinho, R. A. (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 20, 1218-1249 (Pubitemid 43727584)
98. Shi, Y. and Massague, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700 (Pubitemid 36724933)
99. Akhurst, R. J. and Derynck, R. (2001) TGF-β signaling in cancer: a double-edged sword. Trends Cell Biol. 11, S44-S51
100. Hansel, D. E., Kern, S. E. and Hruban, R. H. (2003) Molecular pathogenesis of pancreatic cancer. Annu. Rev. Genomics Hum. Genet. 4, 237-256 (Pubitemid 37392925)
101. Moore, P. S., Beghelli, S., Zamboni, G. and Scarpa, A. (2003) Genetic abnormalities in pancreatic cancer. Mol. Cancer 2, 7
102. Freeman, J. W., DeArmond, D., Lake, M., Huang, W., Venkatasubbarao, K. and Zhao, S. (2004) Alterations of cell signaling pathways in pancreatic cancer. Front. Biosci. 9, 1889-1898 (Pubitemid 38918639)
103. Bardeesy, N., Cheng, K. H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D. et al. (2006) Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20, 3130-3146 (Pubitemid 44790628)
104. Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Fujitani, Y., Fujitani, S., Wright, C. V. and Moses, H. L. (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression. Genes Dev. 20, 3147-3160 (Pubitemid 44790629)
105. Izeradjene, K., Combs, C., Best, M., Gopinathan, A., Wagner, A., Grady, W. M., Deng, C. X., Hruban, R. H., Adsay, N. V., Tuveson, D. A. et al. (2007) Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11, 229-243 (Pubitemid 46349845)
106. Aoyagi, Y., Oda, T., Kinoshita, T., Nakahashi, C., Hasebe, T., Ohkohchi, N. and Ochiai, A. (2004) Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br. J. Cancer 91, 1316-1326 (Pubitemid 39424793)
107. Armstrong, T., Packham, G., Murphy, L. B., Bateman, A. C., Conti, J. A., Fine, D. R., Johnson, C. D., Benyon, R. C. and Iredale, J. P. (2004) Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 10, 7427-7437 (Pubitemid 39487732)
108. Lohr, M., Schmidt, C., Ringel, J., Kluth, M., Muller, P., Nizze, H. and Jesnowski, R. (2001) Transforming growth factor-β1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 61, 550-555 (Pubitemid 32128613)
109. Hendrix, M. J., Seftor, E. A., Kirschmann, D. A., Quaranta, V. and Seftor, R. E. (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann. N. Y. Acad. Sci. 995, 151-161 (Pubitemid 36706622)
110. Mueller, M. M. and Fusenig, N. E. (2004) Friends or foes: bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849 (Pubitemid 39472951)
111. Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M. and Moses, H. L. (2001) Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276, 46707-46713
112. Matrisian, L. M., Cunha, G. R. and Mohla, S. (2001) Epithelial-stromal interactions and tumor progression: meeting summary and future directions. Cancer Res. 61, 3844-3846 (Pubitemid 32695002)
113. Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., Vargo-Gogola, T. C., Begtrup, J. L., Peterson, T. E., Fingleton, B. et al. (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7, 485-496 (Pubitemid 40719131)
114. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L. and Weinberg, R. A. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (Pubitemid 40692295)
115. Radisky, D. C., Kenny, P. A. and Bissell, M. J. (2007) Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J. Cell. Biochem. 101, 830-839 (Pubitemid 47040865)
116. Ortega-Velazquez, R., Gonzalez-Rubio, M., Ruiz-Torres, M. P., Diez-Marques, M. L., Iglesias, M. C., Rodriguez-Puyol, M. and Rodriguez-Puyol, D. (2004) Collagen I upregulates extracellular matrix gene expression and secretion of TGF-β1 by cultured human mesangial cells. Am. J. Physiol. Cell Physiol. 286, C1335-C1343 (Pubitemid 38649983)
117. Worthington, J. J., Klementowicz, J. E. and Travis, M. A. (2011) TGFβ: a sleeping giant awoken by integrins. Trends Biochem. Sci. 36, 47-54
118. Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y. and Tamaki, K. (2005) Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-βsignaling in scleroderma fibroblasts. J. Immunol. 175, 7708-7718 (Pubitemid 41713471)
119. Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y. and Tamaki, K. (2005) Involvement of αvβ5 integrin-mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts. Arthritis Rheum. 52, 2897-2905 (Pubitemid 41369121)
120. Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., Wu, J., Pittet, J. F., Kaminski, N., Garat, C., Matthay, M. A. et al. (1999) The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328 (Pubitemid 29077586)
121. Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J. L., Munger, J. S., Kawakatsu, H., Sheppard, D., Broaddus, V. C. and Nishimura, S. L. (2002) The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J. Cell Biol. 157, 493-507 (Pubitemid 34839812)
122. Yang, Z., Mu, Z., Dabovic, B., Jurukovski, V., Yu, D., Sung, J., Xiong, X. and Munger, J. S. (2007) Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice. J. Cell Biol. 176, 787-793 (Pubitemid 46425539)
123. Spinale, F. G., Escobar, G. P., Mukherjee, R., Zavadzkas, J. A., Saunders, S. M., Jeffords, L. B., Leone, A. M., Beck, C., Bouges, S. and Stroud, R. E. (2009) Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging. Circ. Heart Failure 2, 351-360
124. Karsdal, M. A., Larsen, L., Engsig, M. T., Lou, H., Ferreras, M., Lochter, A., Delaissé, J.-M. and Foged, N. T. (2002) Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277, 44061-44067 (Pubitemid 36157833)
125. Freudenberg, J. and Chen, W. (2007) Induction of Smad1 by MT1-MMP contributes to tumor growth. Int. J. Cancer 121, 966-977 (Pubitemid 47101631)
126. Kessenbrock, K., Plaks, V. and Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67
127. Tatti, O., Vehviläinen, P., Lehti, K. and Keski-Oja, J. (2008) MT1-MMP releases latent TGF-β1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp. Cell Res. 314, 2501-2514
128. Böttinger, E. P., Factor, V. M., Tsang, M. L., Weatherbee, J. A., Kopp, J. B., Qian, S. W., Wakefield, L. M., Roberts, A. B., Thorgeirsson, S. S. and Sporn, M. B. (1996) The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 5877-5882
129. Peinado, H., Quintanilla, M. and Cano, A. (2003) Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 278, 21113-21123 (Pubitemid 36806424)
130. Sun, L., Diamond, M. E., Ottaviano, A. J., Joseph, M. J., Ananthanarayan, V. and Munshi, H. G. (2008) Transforming growth factor-β1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6, 10-20 (Pubitemid 351378162)
131. Horiguchi, K., Shirakihara, T., Nakano, A., Imamura, T., Miyazono, K. and Saitoh, M. (2009) Role of Ras signaling in the induction of snail by transforming growth factor-β. J. Biol. Chem. 284, 245-253
132. Garamszegi, N., Garamszegi, S. P., Samavarchi-Tehrani, P., Walford, E., Schneiderbauer, M. M., Wrana, J. L. and Scully, S. P. (2010) Extracellular matrix-induced transforming growth factor-β receptor signaling dynamics. Oncogene 29, 2368-2380
133. Ju, W., Ogawa, A., Heyer, J., Nierhof, D., Yu, L., Kucherlapati, R., Shafritz, D. A. and Bottinger, E. P. (2006) Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol. 26, 654-667 (Pubitemid 43089776)
134. Phanish, M. K., Wahab, N. A., Colville-Nash, P., Hendry, B. M. and Dockrell, M. E. (2006) The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFβ1 responses in human proximal-tubule epithelial cells. Biochem. J. 393, 601-607 (Pubitemid 43099100)
135. Roberts, A. B., Tian, F., Byfield, S. D., Stuelten, C., Ooshima, A., Saika, S. and Flanders, K. C. (2006) Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 17, 19-27 (Pubitemid 43117513)
136. Medici, D. and Nawshad, A. (2010) Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-κB and LEF-1. Matrix Biol. 29, 161-165
137. Pogribny, I. P., Filkowski, J. N., Tryndyak, V. P., Golubov, A., Shpyleva, S. I. and Kovalchuk, O. (2010) Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int. J. Cancer 127, 1785-1794
138. Tan, C., Costello, P., Sanghera, J., Dominguez, D., Baulida, J., de Herreros, A. G. and Dedhar, S. (2001) Inhibition of integrin linked kinase (ILK) suppresses β-catenin- Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 20, 133-140 (Pubitemid 32142346)
139. Margadant, C. and Sonnenberg, A. (2010) Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 11, 97-105
140. Nishimura, S. L. (2009) Integrin-mediated transforming growth factor-β activation, a potential therapeutic target in fibrogenic disorders. Am. J. Pathol. 175, 1362-1370
141. Hannigan, G., Troussard, A. A. and Dedhar, S. (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat. Rev. Cancer 5, 51-63 (Pubitemid 40052325)
142. Kim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A. et al. (2009) Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J. Clin. Invest. 119, 213-224
143. Rowe, R. G., Lin, Y., Shimizu-Hirota, R., Hanada, S., Neilson, E. G., Greenson, J. K. and Weiss, S. J. (2011) Hepatocyte-derived snail1 propagates liver fibrosis progression. Mol. Cell. Biol. 31, 2392-2403
144. Scarpa, M., Grillo, A. R., Brun, P., Macchi, V., Stefani, A., Signori, S., Buda, A., Fabris, P., Giordani, M. T., De Caro, R. et al. (2011) Snail1 transcription factor is a critical mediator of hepatic stellate cell activation following hepatic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G316-G326
145. Boutet, A., De Frutos, C. A., Maxwell, P. H., Mayol, M. J., Romero, J. and Nieto, M. A. (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25, 5603-5613 (Pubitemid 44847200)
146. Lewis, B. P., Burge, C. B. and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
147. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S. and Johnson, J. M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773 (Pubitemid 40292988)
148. Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R. and Hanahan, D. (2009) MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 23, 2152-2165
149. Dykxhoorn, D. M. (2010) MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70, 6401-6406
150. Inui, M., Martello, G. and Piccolo, S. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11, 252-263
151. Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (Pubitemid 44629897)
152. Szafranska, A. E., Davison, T. S., John, J., Cannon, T., Sipos, B., Maghnouj, A., Labourier, E. and Hahn, S. A. (2007) MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26, 4442-4452 (Pubitemid 47014466)
153. Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P., Liu, C. G., Bhatt, D., Taccioli, C. and Croce, C. M. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, J. Am. Med. Assoc. 297, 1901-1908 (Pubitemid 46707844)
154. Rachagani, S., Kumar, S. and Batra, S. K. (2010) MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett. 292, 8-16
155. Wang, Z., Li, Y., Ahmad, A., Banerjee, S., Azmi, A. S., Kong, D. and Sarkar, F. H. (2011) Pancreatic cancer: understanding and overcoming chemoresistance. Nat. Rev. Gastroenterol. Hepatol. 8, 27-33
156. Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R. and Ruvkun, G. (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906 (Pubitemid 30130993)
157. Lee, Y. S. and Dutta, A. (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025-1030
158. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D. and Slack, F. J. (2005) RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (Pubitemid 40343076)
159. Boyerinas, B., Park, S. M., Shomron, N., Hedegaard, M. M., Vinther, J., Andersen, J. S., Feig, C., Xu, J., Burge, C. B. and Peter, M. E. (2008) Identification of let-7-regulated oncofetal genes. Cancer Res. 68, 2587-2591 (Pubitemid 351556256)
160. Lee, Y. S., Kim, H. K., Chung, S., Kim, K. S. and Dutta, A. (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J. Biol. Chem. 280, 16635-16641 (Pubitemid 41389120)
161. Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J., Shingara, J. et al. (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713-7722 (Pubitemid 47281364)
162. Torrisani, J., Bournet, B., du Rieu, M. C., Bouisson, M., Souque, A., Escourrou, J., Buscail, L. and Cordelier, P. (2009) let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum. Gene Ther. 20, 831-844
163. Kumar, M. S., Erkeland, S. J., Pester, R. E., Chen, C. Y., Ebert, M. S., Sharp, P. A. and Jacks, T. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U.S.A. 105, 3903-3908 (Pubitemid 351723497)
164. Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J. et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (Pubitemid 350235025)
165. Paroo, Z., Ye, X., Chen, S. and Liu, Q. (2009) Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139, 112-122
166. Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M., Handley, D. et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182, 220-229
167. Ji, J., Zhao, L., Budhu, A., Forgues, M., Jia, H. L., Qin, L. X., Ye, Q. H., Yu, J., Shi, X., Tang, Z. Y. et al. (2010) Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinoma. J. Hepatol. 52, 690-697
168. Roderburg, C., Urban, G. W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M. et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218
169. Ogawa, T., Iizuka, M., Sekiya, Y., Yoshizato, K., Ikeda, K. and Kawada, N. (2010) Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 391, 316-321
170. Mongroo, P. S. and Rustgi, A. K. (2010) The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol. Ther. 10, 219-222
171. Peter, M. E. (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843-852
172. Oba, S., Kumano, S., Suzuki, E., Nishimatsu, H., Takahashi, M., Takamori, H., Kasuya, M., Ogawa, Y., Sato, K., Kimura, K. et al. (2010) miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS ONE 5, e13614
173. Chung, A. C., Huang, X. R., Meng, X. and Lan, H. Y. (2010) miR-192 mediates TGF-β/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21, 1317-1325
174. Giovannetti, E., Funel, N., Peters, G. J., Del Chiaro, M., Erozenci, L. A., Vasile, E., Leon, L. G., Pollina, L. E., Groen, A., Falcone, A. et al. (2010) MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 70, 4528-4538
175. Moriyama, T., Ohuchida, K., Mizumoto, K., Yu, J., Sato, N., Nabae, T., Takahata, S., Toma, H., Nagai, E. and Tanaka, M. (2009) MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol. Cancer Ther. 8, 1067-1074
176. Dillhoff, M., Liu, J., Frankel, W., Croce, C. and Bloomston, M. (2008) MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg. 12, 2171-2176
177. Tao, J., Lu, Q., Wu, D., Li, P., Xu, B., Qing, W., Wang, M., Zhang, Z. and Zhang, W. (2011) microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol. Rep. 25, 1721-1729
178. Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T. and Fujita, N. (2010) AP-1-dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol. Res. 19, 23-33
179. Olson, P. and Hanahan, D. (2009) Cancer. Breaching the cancer fortress. Science 324, 1400-1401
180. Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E., Tao, Q., Vanhove, M., Lejeune, A. et al. (2009) Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res. 69, 1517-1526